Fresenius Medical Care AG (FMS) Form 6-K — Aug 3, 2026
Fresenius Medical Care AG appointed Cassie McLean as a member of its Management Board and Chief Executive Officer of the operating segment Care Delivery, effective August 1, 2026. Ms. McLean succeeds Craig Cordola and will assume direct accountability for the global clinic business, including Fresenius Kidney Care in the U.S. and Care Delivery International.
Key figures
- Dialysis Clinics
- 3513
- Patients In Clinics
- 290000
- Patients Worldwide
- 4500000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.